Daiichi Sankyo Co., Ltd. - Sponsored ADR (OTCMKTS:DSNKY - Get Free Report) shot up 0.6% on Friday . The company traded as high as $22.12 and last traded at $22.03. 179,839 shares were traded during mid-day trading, a decline of 18% from the average session volume of 219,220 shares. The stock had previously closed at $21.90.
Wall Street Analysts Forecast Growth
Separately, Nomura Securities upgraded shares of Daiichi Sankyo to a "strong-buy" rating in a research note on Friday, June 6th.
Read Our Latest Stock Report on Daiichi Sankyo
Daiichi Sankyo Stock Up 0.6%
The company has a quick ratio of 1.85, a current ratio of 2.53 and a debt-to-equity ratio of 0.06. The business has a 50-day simple moving average of $24.34 and a two-hundred day simple moving average of $24.73. The stock has a market capitalization of $41.73 billion and a P/E ratio of 21.39.
Daiichi Sankyo (OTCMKTS:DSNKY - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $0.30 earnings per share for the quarter. Daiichi Sankyo had a net margin of 15.65% and a return on equity of 17.92%. The business had revenue of $3.40 billion for the quarter. Equities research analysts forecast that Daiichi Sankyo Co., Ltd. - Sponsored ADR will post 0.73 earnings per share for the current fiscal year.
About Daiichi Sankyo
(
Get Free Report)
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Daiichi Sankyo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daiichi Sankyo wasn't on the list.
While Daiichi Sankyo currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
